Exact Sciences

Exact Sciences is a molecular diagnostics company best known for Cologuard, an FDA-approved at-home colorectal cancer screening test that uses multi-target stool DNA and AI-powered analysis to detect colorectal cancer and advanced precancerous lesions non-invasively. The company also offers Oncotype DX genomic tests for breast, prostate, and colon cancer prognosis, helping oncologists determine which patients will benefit from chemotherapy. With over 15 million Cologuard tests completed and integration into major health system screening programs, Exact Sciences has transformed cancer screening by making molecular diagnostics accessible through at-home collection.